Mitochondrial DNA, diabetes and pancreatic pathology in Kearns-Sayre syndrome.
Mitochondrial DNA (mtDNA) mutations are associated with diabetes mellitus but their role in the onset of hyperglycaemia is unclear. A patient presented with diabetes requiring insulin therapy at the age of 7 years, followed by diagnosis of Kearns-Sayre syndrome (KSS). Beta-cell function was absent at age 19 years as shown by lack of glucose-stimulated C-peptide secretion. Following development of a cardiac conduction defect the patient died aged 21 years. Analysis of mtDNA in blood and several tissues revealed related re-arranged deletions, duplications and deletion dimers in addition to normal mtDNA with the highest levels of duplications in kidney and blood. Pancreatic tissue from the KSS patient was compared with tissue from an insulin-dependent diabetic patient with a similar clinical history of diabetes. Islets in KSS were small, regular in shape and contained predominantly glucagon-containing cells with no evidence of beta cells. In comparison, a small number of beta cells were present in some of the larger more irregularly-shaped islets from the insulin-dependent diabetic patient. These data together suggest that in KSS the loss of beta cells at the onset of diabetes is less disruptive to islet architecture: a small proportion of beta cells or their gradual destruction over a long period would allow retention of islet shape. Abnormal function of the re-arranged mtDNA could affect both development and function of pancreatic islet cells since glucose-stimulated insulin secretion is energy dependent.
Poulton
J
J
Department of Paediatrics, John Radcliffe Hospital, Oxford, UK.
O'Rahilly
S
S
Morten
K J
KJ
Clark
A
A
D000328:Adult; D017668:Age of Onset; D002096:C-Peptide / Q000097:blood; D002648:Child; D004272:DNA, Mitochondrial / Q000032:analysis / Q000235:genetics*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000235:genetics* / Q000473:pathology; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D007124:Immunoenzyme Techniques; D007328:Insulin / Q000032:analysis / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000473:pathology; D007625:Kearns-Sayre Syndrome / Q000150:complications / Q000235:genetics* / Q000473:pathology; D007668:Kidney / Q000378:metabolism; D009928:Organ Specificity; D010179:Pancreas / Q000473:pathology*; D017384:Sequence Deletion
D002096:C-Peptide; D004272:DNA, Mitochondrial; D007328:Insulin